125 related articles for article (PubMed ID: 3147171)
1. Blood group antigens in epithelial tumours of the urinary bladder.
Marek J; Hradec E; Hanus M; Smolová H
Czech Med; 1988; 11(3):137-45. PubMed ID: 3147171
[TBL] [Abstract][Full Text] [Related]
2. [The specific erythrocyte adherence method in the study of ABH antigens on normal and neoplastic bladder epithelium].
Ongaro G; Issi M; Gallo T; Garbeglio A; Ranieri A; Dalla Palma P
Quad Sclavo Diagn; 1983 Jun; 19(2):242-61. PubMed ID: 6676774
[TBL] [Abstract][Full Text] [Related]
3. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
[TBL] [Abstract][Full Text] [Related]
4. The distribution of ABO(H) isoantigens in urinary bladder tumours.
Baranyay F; Knels R; Somogyi L
Acta Med Hung; 1992-1993; 49(1-2):129-36. PubMed ID: 1296182
[TBL] [Abstract][Full Text] [Related]
5. [Clinical course, DNA-Feulgen cytophotometry and ABO antigenicity of bladder papillomas of low malignancy degree].
Hofstädter F; Friessnig F; Jakse G; Lederer B
Verh Dtsch Ges Pathol; 1978; 62():374. PubMed ID: 371217
[No Abstract] [Full Text] [Related]
6. [The study of the ABH isoantigen of bladder tumors].
Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
[TBL] [Abstract][Full Text] [Related]
7. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
Juhl BR
Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of the expression of A, B isoantigens with its precursor H antigen in transitional cell carcinoma and the clinical signification of the expression].
Yang SC
Zhonghua Wai Ke Za Zhi; 1990 Oct; 28(10):631-3, 639. PubMed ID: 2086062
[TBL] [Abstract][Full Text] [Related]
9. [Significance of ABH antigens and CEA for the prognosis of urothelial tumors].
Hofstädter F; Jakse G
Wien Klin Wochenschr; 1982 Jul; 94(14):366-8. PubMed ID: 7147976
[TBL] [Abstract][Full Text] [Related]
10. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
Proca E; Lucan M; Pîslăraşu M
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
[No Abstract] [Full Text] [Related]
11. Blood group antigens in urothelium in transitional cell carcinoma.
Giraldo AA; Ruby SG; Humes JJ
Ann Clin Lab Sci; 1983; 13(4):307-14. PubMed ID: 6354063
[TBL] [Abstract][Full Text] [Related]
12. [Correlations between grading and presence of blood group isoantigens in papillary urothelial-cell carcinoma of the bladder with low grade malignancy].
Mattarozzi A; Zanella L; Bacchini P; Bertoni F; Ferramosca B
Pathologica; 1985; 77(1050):395-400. PubMed ID: 3834371
[No Abstract] [Full Text] [Related]
13. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713
[TBL] [Abstract][Full Text] [Related]
14. A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma.
Busch C; Malmström PU; Norlen BJ; Sällström J; Brodin T; Lundblad A
Anticancer Res; 1988; 8(1):81-7. PubMed ID: 3358642
[TBL] [Abstract][Full Text] [Related]
15. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
Gelabert Mas A; Corominas J; Arango O
Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
[No Abstract] [Full Text] [Related]
16. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
17. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
18. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
Vallancien G; Rouger P; Leclerc JP; Kuss R
Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
[TBL] [Abstract][Full Text] [Related]
19. [Blood group ABO (H) cell surface antigens in bladder tumours invading the chorion. Prognostic value of their determination by immunofluorescence. Retrospective study of one hundred and twenty-five cases].
Vacant J; Le Portz B; Augustin I; Hammou JC; Fella C; Délignières S; Maïolini R; Masseyeff R; Abelanet R; Steg A
Sem Hop; 1982 May; 58(21):1295-300. PubMed ID: 6287585
[TBL] [Abstract][Full Text] [Related]
20. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
Tan LB; Chiang C; Huang CH; Lin LM
Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
